Potent antagonists for the human adenosine A2B receptor. Derivatives of the triazolotriazine adenosine receptor antagonist ZM241385 with high affinity

This publication has 21 references indexed in Scilit:

• 1,3-dialkylxanthine derivatives having high potency as antagonists at human A2B adenosine receptors
  Drug Development Research, 1999
• A Functional Screening of Adenosine Analogues at the Adenosine A_2BReceptor: A Search for Potent Agonists
  Nucleosides and Nucleotides, 1998
• Adenosine A2B receptors: a novel therapeutic target in asthma?
  Trends in Pharmacological Sciences, 1998
• Characterization of the human brain putative A_2B adenosine receptor expressed in Chinese hamster ovary (CHO.A_2B4) cells
  British Journal of Pharmacology, 1996
• Recent developments in selective agonists and antagonists acting at purine and pyrimidine receptors
  Drug Development Research, 1996
• The in vitro pharmacology of ZM 241385, a potent, non‐xanthine, A_2a selective adenosine receptor antagonist
  British Journal of Pharmacology, 1995
• Adenine isosteres with bridgehead nitrogen. Part 1. Two independent syntheses of the [1,2,4]triazolo[1,5-a][1,3,5]triazine ring system leading to a range of substituents in the 2, 5 and 7 positions
  Journal of the Chemical Society, Perkin Transactions 1, 1995
• Functional characterization of the A2b adenosine receptor in NIH 3T3 fibroblasts
  Biochemical Pharmacology, 1994
• Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists
  Journal of Medicinal Chemistry, 1988
• Subclasses of adenosine receptors in the central nervous system: Interaction with caffeine and related methylxanthines
  Cellular and Molecular Neurobiology, 1983